14-30878834-G-T
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PM1PM2PP3_StrongPP5
The NM_004086.3(COCH):c.263G>T(p.Gly88Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,874 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G88E) has been classified as Uncertain significance.
Frequency
Consequence
NM_004086.3 missense
Scores
Clinical Significance
Conservation
Publications
- nonsyndromic genetic hearing lossInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- autosomal dominant nonsyndromic hearing loss 9Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- hearing loss, autosomal recessive 110Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004086.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| COCH | NM_004086.3 | MANE Select | c.263G>T | p.Gly88Val | missense | Exon 5 of 12 | NP_004077.1 | ||
| COCH | NM_001347720.2 | c.458G>T | p.Gly153Val | missense | Exon 4 of 11 | NP_001334649.1 | |||
| COCH | NM_001135058.2 | c.263G>T | p.Gly88Val | missense | Exon 4 of 11 | NP_001128530.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| COCH | ENST00000396618.9 | TSL:1 MANE Select | c.263G>T | p.Gly88Val | missense | Exon 5 of 12 | ENSP00000379862.3 | ||
| COCH | ENST00000216361.9 | TSL:1 | c.458G>T | p.Gly153Val | missense | Exon 4 of 11 | ENSP00000216361.5 | ||
| COCH | ENST00000475087.5 | TSL:1 | c.263G>T | p.Gly88Val | missense | Exon 4 of 11 | ENSP00000451528.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000795 AC: 2AN: 251488 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461874Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 727238 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Autosomal dominant nonsyndromic hearing loss 9 Pathogenic:1
PM1;PM5;PM2_Supporting;PP3
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The Gly88Val varian t in COCH has not been reported in individuals with hearing loss or in large pop ulation studies. Computational analyses (biochemical amino acid properties, cons ervation, AlignGVGD, PolyPhen2, and SIFT) suggest that the Gly88Val variant may impact the protein, though this information is not predictive enough to determin e pathogenicity. A similar variant at this position, Gly88Glu, has been reported as pathogenic in the literature (Robertson 1998; Jao 2012), though this change may not reflect the impact of the more conservative Gly to Val change. In summar y, additional data is needed to determine the clinical significance of this vari ant.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at